Physician profile
Asmir Selimovic
NPI 1922473784
$615.18
in general payments reported to CMS, 2019-2025
8 companies · $251 in 2025
The $251 reported for 2025 was more than what 98% of Anesthesiologist Assistant providers received nationally (typical 2025 total: $34.52).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $140 · 2022: $73.08 · 2023: $106 · 2024: $45.10 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $346.67 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $64.21 | 2023-2024 | Bridion |
| Atricure, INC. | $62.11 | 2022-2025 | Atricure Cryoice Cryoablation System (Cryo2) |
| Edwards Lifesciences Corporation | $54.28 | 2023-2025 | Mitris Resilia Mitral Valve, Edwards Intuity Elite Valve System |
| Baxter Healthcare | $29.20 | 2022 | |
| Medtronic, INC. | $25.42 | 2022 | |
| Fisher & Paykel Healthcare INC | $21.97 | 2023 | Fisher & Paykel Healthcare |
| Cvrx, INC. | $11.32 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asmir Selimovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.